The next board meeting for Orchestra BioMed Holdings Inc is on 27 Mar 2025 for the purpose of Orchestra BioMed Holdings Inc Fourth Quarter Earnings Results for 2024See details
Orchestra BioMed Holdings Inc has a share price target of US$ 15, revenue growth forecast of 15.9%, and profit growth estimate of -23.9% for FY24, based on top 7 analyst calls.